Chiral version of Ritalin d-methylphenidate regulatory update

CELG received U.S. Patent No. 5,922,736 covering methods and formulations of a once-daily version of d-methylphenidate, the chirally pure version of Novartis Pharma AG's Ritalin to treat attention def...